Clinical Trial Update: Clinical Study of Previously Untreated Patients With Malignant Melanoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating treatment in previously untreated malignant melanoma patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Melanoma

Snippet

Sponsor: Clavis Pharma | Conditions: Malignant Melanoma, Neoplasm Metastasis | Phase 2 | Status: COMPLETED